Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of effect of including these potential shares was antidilutive

v3.22.2.2
Summary of Significant Accounting Policies (Details) - Schedule of effect of including these potential shares was antidilutive - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities 15,106,097 7,720,000 15,346,097 7,720,000
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities 8,145,000 7,720,000 8,385,000 7,720,000
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities 1,239,647 1,239,647  
Convertible Note [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Potentially dilutive securities [1] 5,721,450 5,721,450
[1] Assumed the convertible note was converted into shares of common stock of the Company at a conversion price of $0.65 per share.